In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a population-based study (Taichung Community Health Study)
- 29 October 2007
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 67 (3), 432-433
- https://doi.org/10.1136/ard.2007.073601
Abstract
Hyperuricemia and metabolic syndrome (MetS) have been shown to increase the risk of hypertension, type 2 diabetes mellitus, and cardiovascular disease (CVD) and increase the risk of total and CVD mortality.1 2 Insulin resistance (IR) and central obesity have been recognised as the common underlying mechanism.3 4 The association between hyperuricemia and MetS has been studied, but most of these studies focused on Caucasians.5 In this study, we examined this relationship using five different definitions (proposed by the World Health Organization (WHO), the National Cholesterol Education Program Third Adult Treatment Panel (NCEP-ATPIII), the modified NCEP-ATPIII, the International Diabetes Federation (IDF), and the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI)) in Taiwan.6 A total of …This publication has 10 references indexed in Scilit:
- Associations of Serum Uric Acid With Markers of Inflammation, Metabolic Syndrome, and Subclinical Coronary AtherosclerosisAmerican Journal of Hypertension, 2007
- Recent developments in diet and goutCurrent Opinion in Rheumatology, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Leptin Predicts a Worsening of the Features of the Metabolic Syndrome Independently of ObesityObesity Research, 2005
- Serum Uric Acid Independently Predicts Mortality in Patients with Significant, Angiographically Defined Coronary DiseaseAmerican Journal of Nephrology, 2005
- Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular diseaseSeminars in Nephrology, 2005
- Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?Circulation, 2004
- Relationship to Insulin Resistance of the Adult Treatment Panel III Diagnostic Criteria for Identification of the Metabolic SyndromeDiabetes, 2004
- The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged MenJAMA, 2002
- Do Different Dimensions of the Metabolic Syndrome Change Together Over Time?Diabetes Care, 2001